Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
203M
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
40.3M
-
Shares change
-
+588K
-
Total reported value, excl. options
-
$1.86B
-
Value change
-
+$41.3M
-
Number of buys
-
87
-
Number of sells
-
-49
-
Price
-
$46.19
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2020
156 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.3M shares
of 203M outstanding shares and own 19.89% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (7.59M shares), BlackRock Inc. (4.8M shares), VANGUARD GROUP INC (3.88M shares), STATE STREET CORP (1.87M shares), Cormorant Asset Management, LP (1.56M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares), PERCEPTIVE ADVISORS LLC (1.4M shares), Polar Capital Holdings Plc (1.38M shares), Invesco Ltd. (1.13M shares), and EVENTIDE ASSET MANAGEMENT, LLC (932K shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.